KBI Biopharma is a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO) that is dedicated to accelerating the development of groundbreaking discoveries into life-changing biological products. Their ultimate goal is to expand global access and ensure that critical medicines reach patients in need. With a team based in the US and Europe, KBI Biopharma boasts world-class analytical capabilities, offering efficient process development and clinical and commercial cGMP manufacturing services for mammalian, microbial, and cell therapy programs.

Driven by their core values of high standards, trust and respect, learning and growth, and collaboration, KBI Biopharma strives for excellence, fosters an environment of open communication, empowers their employees, and promotes cross-functional teamwork. Their dedicated team takes great pride in meeting the needs of their customers, knowing that their work has a direct impact on patients' lives. With locations in various countries, including Switzerland and Belgium, KBI Biopharma is committed to delivering quality and execution in the pharmaceutical industry